Upcoming Conference
Inland Northwest, September 12, 2018

California Life Sciences Association Announces Expanded Sacramento & Washington Presence, Adds Three to Advocacy Team

| Apr 19, 2017 | California, Washington

California Life Sciences Association (CLSA), the state’s premier public policy and business solutions organization representing California’s life sciences sector, today announced a major expansion to its advocacy team, hiring three new government relations directors based in its Sacramento and Washington, D.C. offices, bringing its in-house advocacy staff count to nine...[ Read More ]

California NAACP and Seniors Join Patient Advocacy Groups To Raise Concerns About SB 1010

| Jun 22, 2016 | California

SACRAMENTO – California NAACP joins the California Chronic Care Coalition, California Senior Advocates League, Friedreich’s Ataxia Research Alliance (FARA), Council for Citizens Against Government Waste, TechNet, California Hepatitis C Task Force and others to voice concerns regarding SB 1010, a bill by State Sen. Ed Hernandez, which prioritizes paperwork, red...[ Read More ]

CLSA Elects Leaders from Merck, Organovo, St. Jude Medical to Board

| May 24, 2016 | California

SAN FRANCISCO & SAN DIEGO, CA – Today, California Life Sciences Association (CLSA) announced its board of directors has appointed three new members: Ben Thorner, Vice President, BD&L and Head of North American Innovation Hubs, Merck; Keith Murphy, Chairman and Chief Executive Officer, Organovo; and Dave Anderson, Vice President, Merger...[ Read More ]

Patients, Life Sciences Community launch digital campaign in opposition of SB 1010

| May 20, 2016 | California

SACRAMENTO – Patients and the life sciences community have partnered to protect access to new medicines and oppose SB 1010. The bill, by Sen. Ed Hernandez, prioritizes paperwork and bureaucracy over research, and instead of improving patient access and affordability, places patients in California at the end of the line....[ Read More ]

CLSA applauds bill to increase Medicare patient access to medical technologies

| Apr 21, 2016 | California

H.R. 5009 bridges Medicare patient access gaps and modernizes policies to allow coverage of technologies approved through FDA’s expedited review process Washington, DC (April 21, 2016) – California Life Sciences Association (CLSA), the statewide public policy organization representing over 750 of California’s leading life science innovators, lauded the introduction of...[ Read More ]

California Life Sciences Association issues statement on SB 1010

| Apr 14, 2016 | California

Sacramento, CA--California Life Sciences Association (CLSA), the statewide public policy organization representing over 750 of California’s leading life sciences innovators, issued the following statement opposing SB 1010. This statement can be attributed to Sara Radcliffe, President & CEO, California Life Sciences Association (CLSA): “As innovators in the life sciences sector...[ Read More ]